PuSH - Publication Server of Helmholtz Zentrum München

Morath, C.* ; Schmied, B.* ; Mehrabi, A.* ; Weitz, J.* ; Schmidt, J.* ; Werner, J.* ; Büchler, M.W.* ; Morcos, M.* ; Nawroth, P.P.* ; Schwenger, V.* ; Doehler, B.* ; Opelz, G.* ; Zeier, M.*

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.

Clin. Transplant. 23, 33-36 (2009)
DOI Order publishers version
Open Access Green as soon as Postprint is submitted to ZB.
Renin-angiotensin system blockade retards the progression of diabetic and non-diabetic chronic kidney disease of the native kidneys. Though most patients suffer from a significant renal insufficiency (chronic kidney disease stage III) and a concomitant heart disease after renal transplantation, there is up to now no evidence supporting the use of inhibitors of the renin-angiotensin system in these patients. We wish to summarize the available evidence on the use of inhibitors of the renin-angiotensin system after renal transplantation. We specifically discuss potential beneficial as well as adverse effects of a renin-angiotensin system blockade. In addition, we review their influence on morphologic and biochemical markers as well as on renal function, graft and patient survival after renal transplantation.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
ISSN (print) / ISBN 0902-0063
e-ISSN 1399-0012
Quellenangaben Volume: 23, Issue: , Pages: 33-36 Article Number: , Supplement: ,
Publisher Wiley
Reviewing status Peer reviewed
Institute(s) Institute for Pancreatic Beta Cell Research (IPI)